MedPath

Impact of pre transplant infections on outcome after Live Donor Liver Transplant

Not Applicable
Conditions
Health Condition 1: K742- Hepatic fibrosis with hepatic sclerosis
Registration Number
CTRI/2021/07/034810
Lead Sponsor
Fortis Escorts Heart Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients more than 18 years planned for liver transplant surgery

Exclusion Criteria

Age less than 18 years

Patient refusal

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the impact of pre-transplant infections on the outcome after live donor liver transplant (LDLT) in terms of <br/ ><br>1.Length of ICU stay <br/ ><br>2.In hospital mortality <br/ ><br>3.Post-transplant infectious complicationsTimepoint: Upto 21 days post transplant surgery
Secondary Outcome Measures
NameTimeMethod
1.Post-transplant acute kidney injury <br/ ><br>2.Incidence of acute & hyper acute rejectionsTimepoint: Upto 21 days post transplant surgery
© Copyright 2025. All Rights Reserved by MedPath